Lightwave Logic is valued at $2B with just 34 employees and zero revenue after 34 years in business. x.com
Bluechip
Value Investor, Short Seller
Lightwave Logic's real market is too small for the bull case: even with 100% share it could reach only about $200M in sales. Of a $24B transceiver market, silicon photonics is 10-15% of the bill of materials, capping the modulator TAM near $2B; netting out VCSELs, EMLs and legacy 10G-800G products that ship as is leaves a real SAM of maybe $200M. Due diligence with people who evaluated the technology found minimal to zero interest from Tier 1 optical vendors. x.com x.com x.com
Lightwave Logic is vulnerable as retail enthusiasm fades for a story stock with close to no revenue, more than 10 years of failed promises and a minuscule TAM, since its material goes into only one of many optical components in a PIC. Aurora's fall after launching services while facing years of losses shows how retail favorites lose support once reality arrives. x.com
Lightwave Logic's valuation is too high, with commercialization still a long way off and current revenue offering little guidance. Its smartest move is integrating with existing silicon photonics and InP supply chains rather than replacing them, and its 2026 foundry partnership has won market credibility, reflected in a tenfold rise over the past year. It is not worth chasing; dips are the better entry. x.com
Lightwave Logic is a genuinely interesting lottery ticket that wins big if electro-optic polymers become the standard. Its Tower Semiconductor deal puts its modulators, targeting 400G per lane, into a widely used foundry design kit open to any Tower customer, including Nvidia. Its CEO was at Oclaro when Lumentum bought it and advised on IPG's coherent division, also sold to Lumentum, a playbook it could repeat. A 70% run could be a potential top signal, but it does not look topped yet. x.com
Lightwave Logic's multibillion-dollar market cap looks hard to justify because it has technology and products but almost no sales. Its Perkinamine polymer modulators use less power, are smaller and twice as efficient as lithium niobate or silicon, and fit existing silicon photonics lines. But 2025 revenue was only $237K against a $20.3M net loss and -$15.1M free cash flow, with losses expected through 2027. The market is betting on adoption as CPO expands, so expect 20% swings on news. x.com
Lightwave Logic is not a buy yet because commercialization is too far off. Its technology is brilliant and clearly disruptive, and the pipeline is moving, with four customers including Marvell/Polarion in the prototype-to-product stage and one or two more expected by Q3 2026. But high-volume production is not targeted until the second half of 2027. It is a classic high-beta story that swung from $5 to $18 and back to $9, and it could become an interesting investment in 6 to 18 months. x.com
Lightwave Logic could be one of the biggest winners if it executes, and the odds improve daily. It licenses its electro-optic polymer platform like Arm, with high margins and low capex; cash lasts to end-2027, matching its target to move Stage 3 customers into production. Polymer devices passed 2,000 hours of damp-heat testing, the telecom-grade bar. If 2-3 customers ramp, royalties could reach $30-50M, worth up to about $1.25B at 25x. Much is priced in, so adding on pullbacks is best. x.com
Lightwave Logic's $1.8B valuation makes no sense for a company without revenue, making it the Rigetti of photonics. Foxconn's optical arm Shunsin, which handles live packaging, assembly and testing for NVIDIA's co-packaged optics, is valued at only $1.4B, and Sivers, a laser source for Jabil and Marvell, was valued at a third of Lightwave earlier this week. Institutions appear to have piled into the wrong name on the strength of a development test agreement with Tower Semiconductor. x.com x.com
Lightwave Logic is not a buy here because its run has carried it into long-term resistance on the monthly chart while the company still doesn't appear to make any money. x.com
Lightwave Logic could break $100 quickly because its Perkinamine electro-optic polymers modulate data faster than lithium niobate or indium phosphide can, possibly the only path as the industry moves from 1.6T to 3.2T. Four Fortune 500 companies are in Stage 3 design wins, its pure royalty model needs no capex, and $70M of cash, no debt and a Tower Semiconductor partnership carry it through 2027. The risk is extreme concentration: a few unnamed customers control its fate. x.com
LightPath Technologies is a good long-term buy because revenue has doubled while its valuation is now below $600 million. It is hard to see it not doing well long term; LightPath still looks like a $10 billion company in five years. x.com x.com